Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1965 1
1995 2
1996 2
1997 1
1998 2
1999 2
2000 1
2001 2
2002 3
2003 1
2004 2
2006 1
2007 3
2008 8
2009 5
2010 2
2011 3
2012 5
2013 4
2014 3
2015 5
2016 4
2017 7
2018 5
2019 5
2020 12
2021 7
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Results by year
Filters applied: . Clear all
Page 1
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, Lesca G, Ville D, Milh M, Villard L, Afenjar A, Chantot-Bastaraud S, Mignot C, Lardennois C, Nava C, Schwarz N, Gérard M, Perrin L, Doummar D, Auvin S, Miranda MJ, Hempel M, Brilstra E, Knoers N, Verbeek N, van Kempen M, Braun KP, Mancini G, Biskup S, Hörtnagel K, Döcker M, Bast T, Loddenkemper T, Wong-Kisiel L, Baumeister FM, Fazeli W, Striano P, Dilena R, Fontana E, Zara F, Kurlemann G, Klepper J, Thoene JG, Arndt DH, Deconinck N, Schmitt-Mechelke T, Maier O, Muhle H, Wical B, Finetti C, Brückner R, Pietz J, Golla G, Jillella D, Linnet KM, Charles P, Moog U, Õiglane-Shlik E, Mantovani JF, Park K, Deprez M, Lederer D, Mary S, Scalais E, Selim L, Van Coster R, Lagae L, Nikanorova M, Hjalgrim H, Korenke GC, Trivisano M, Specchio N, Ceulemans B, Dorn T, Helbig KL, Hardies K, Stamberger H, de Jonghe P, Weckhuysen S, Lemke JR, Krägeloh-Mann I, Helbig I, Kluger G, Lerche H, Møller RS. Wolff M, et al. Among authors: mary s. Brain. 2017 May 1;140(5):1316-1336. doi: 10.1093/brain/awx054. Brain. 2017. PMID: 28379373
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP). Ramachandran A, et al. Among authors: mary s. Diabetologia. 2006 Feb;49(2):289-97. doi: 10.1007/s00125-005-0097-z. Epub 2006 Jan 4. Diabetologia. 2006. PMID: 16391903 Clinical Trial.
Allosteric modulation of ghrelin receptor signaling by lipids.
Damian M, Louet M, Gomes AAS, M'Kadmi C, Denoyelle S, Cantel S, Mary S, Bisch PM, Fehrentz JA, Catoire LJ, Floquet N, Banères JL. Damian M, et al. Among authors: mary s. Nat Commun. 2021 Jun 24;12(1):3938. doi: 10.1038/s41467-021-23756-y. Nat Commun. 2021. PMID: 34168117 Free PMC article.
Glycated proteome: from reaction to intervention.
Kulkarni MJ, Korwar AM, Mary S, Bhonsle HS, Giri AP. Kulkarni MJ, et al. Among authors: mary s. Proteomics Clin Appl. 2013 Jan;7(1-2):155-70. doi: 10.1002/prca.201200101. Proteomics Clin Appl. 2013. PMID: 23184864 Review.
Immune response to chemically modified proteome.
Bhat S, Mary S, Banarjee R, Giri AP, Kulkarni MJ. Bhat S, et al. Among authors: mary s. Proteomics Clin Appl. 2014 Feb;8(1-2):19-34. doi: 10.1002/prca.201300068. Proteomics Clin Appl. 2014. PMID: 24375944 Review.
Gain-of-function GABRB3 variants identified in vigabatrin-hypersensitive epileptic encephalopathies.
Absalom NL, Liao VWY, Kothur K, Indurthi DC, Bennetts B, Troedson C, Mohammad SS, Gupta S, McGregor IS, Bowen MT, Lederer D, Mary S, De Waele L, Jansen K, Gill D, Kurian MA, McTague A, Møller RS, Ahring PK, Dale RC, Chebib M. Absalom NL, et al. Among authors: mary s. Brain Commun. 2020 Oct 1;2(2):fcaa162. doi: 10.1093/braincomms/fcaa162. eCollection 2020. Brain Commun. 2020. PMID: 33585817 Free PMC article.
94 results